How Far Could We Go with Open Data – A Case Study for TRPV1 Antagonists

Publicly open databases of small compounds have become an indispensable tool for chemoinformaticians for collection and preparation of datasets suitable for drug discovery questions. Since these databases comprise compounds coming from structure-activity relationship (SAR) studies performed by diffe...

Descripción completa

Detalles Bibliográficos
Autores principales: Tsareva, Daria A, Ecker, Gerhard F
Formato: Online Artículo Texto
Lenguaje:English
Publicado: WILEY-VCH Verlag 2013
Materias:
Full Papers
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3743172/
https://www.ncbi.nlm.nih.gov/pubmed/23956804
http://dx.doi.org/10.1002/minf.201300019

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3743172/
https://www.ncbi.nlm.nih.gov/pubmed/23956804
http://dx.doi.org/10.1002/minf.201300019

Ejemplares similares